These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11521426)

  • 21. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
    Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative measurement of retinal thickness in patients with diabetic macular edema is useful for evaluation of therapeutic agents.
    Funatsu H; Yamashita H; Shimizu E; Mimura T; Nakamura S; Hori S
    Diabetes Res Clin Pract; 2004 Dec; 66(3):219-27. PubMed ID: 15536018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On a classification of changes in the eye fundus as observed in diabetes mellitus].
    Evgrafov VIu; Batmanov IuE
    Vestn Oftalmol; 2004; 120(4):11-4. PubMed ID: 15384839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
    Kim SJ; Equi R; Bressler NM
    Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Macular edema after cataract surgery in diabetic patients without retinopathy].
    Jurecka T; Bátková Z; Ventruba J; Synek S
    Cesk Slov Oftalmol; 2007 Jul; 63(4):274-84. PubMed ID: 17682607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of retinal thickness in macular region in diabetic patients with RTA analyzer].
    Polaczek-Krupa B; Grabska-Liberek I; Terelak-Borys B
    Klin Oczna; 2009; 111(4-6):119-21. PubMed ID: 19673438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of cytomedines on the hemostatic and antioxidant potential of patients in the early stage of diabetic retinopathy].
    Gavrilova NA; Fedorova TN; Trofimova SV; Pimenov IV; Lanevskaia NI
    Eksp Klin Farmakol; 2004; 67(5):60-2. PubMed ID: 15559640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunocorrective therapy of diabetic retinopathy patients].
    Degtiarenko TV; Kashintseva LT; Saldan IR; Kozina LV
    Oftalmol Zh; 1987; (7):387-91. PubMed ID: 3441331
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of therapy with blood component (activated autoplasma) on blood glutathione level in patients with vascular abnormalities on the fundus oculi].
    Filina AA; Mukha AI; Lysenko VS
    Vestn Oftalmol; 2000; 116(5):29-31. PubMed ID: 11221375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The classification of diabetic retinopathy].
    Munteanu G
    Oftalmologia; 1993; 37(3):207-9. PubMed ID: 8338820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic retinopathy. An ophthalmoscopic study with a discussion of the morphologic changes and the pathogenetic factors in this disease.
    LARSEN HW
    Acta Ophthalmol Suppl; 1960; Suppl 60():1-89. PubMed ID: 14414263
    [No Abstract]   [Full Text] [Related]  

  • 33. [Malignant progressive diabetic retinopathy].
    Setogawa T
    Nihon Ganka Kiyo; 1966 Apr; 17(4):482-6. PubMed ID: 6006514
    [No Abstract]   [Full Text] [Related]  

  • 34. Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging.
    Korkushko OV; Khavinson VKh; Shatilo VB; Antonyuk-Shcheglova IA
    Bull Exp Biol Med; 2006 Sep; 142(3):356-9. PubMed ID: 17426848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results].
    Khavinson VKh; Kuznik BI; Ryzhak GA
    Adv Gerontol; 2013; 26(1):20-37. PubMed ID: 24003726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Considerations on the ophthalmoscopic picture and pathogenic problems of diabetic retinopathy].
    MARCOS VILLA L
    Archivos Soc Oftalmol Hisp Am; 1952 Jul; 12(7):733-7. PubMed ID: 13008784
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical treatment for diabetic retinopathy].
    Sakamoto T
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():360-3. PubMed ID: 23156419
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of peptide bioregulators in ophthalmology].
    Khavinson VKh; Trofimova SV
    Vestn Oftalmol; 1999; 115(5):42-5. PubMed ID: 10582024
    [No Abstract]   [Full Text] [Related]  

  • 39. [Application of peptide bioregulators in gerontology: results and perspectives].
    Khavinson VKh; Morozov VG
    Klin Med (Mosk); 2000; 78(8):81-4. PubMed ID: 11019535
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy of diabetic retinopathy.
    Macri F
    Eye Ear Nose Throat Mon; 1970 Dec; 49(12):530-1. PubMed ID: 5524414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.